H Anan, A Matsumoto, T Hamachi, Y Yoshimine, Y Morita, K Maeda
Index: J. Endod. 22 , 668-673, (1996)
Full Text: HTML
To investigate the effects of a combination of an antibacterial agent (ofloxacin) and a collagenase inhibitor (FN-439) in the root canal treatment of apical periodontitis, we studied the healing process of experimentally induced periapical lesions in rats by using immunohistochemical methods. With a topical application of a combination of ofloxacin and FN-439 following experimentally induced periapical lesions, both neutrophils and macrophages became significantly decreased in number, while active cementogenesis and extensive bone formation were seen in the periapical region. However, the use of ofloxacin alone also demonstrated a beneficial effect on periapical inflammation and healing. Therefore, it is suggested that ofloxacin is powerful against bacterial infection whether FN-439 is added. The only observed effect of a combination of ofloxacin and FN-439 is that it may more effectively inhibit osteoclastic bone resorption and activate the remodeling of the apical periodontal tissue if this combined medicament is used in a stage of active bone destruction characterized by high production of tissue collagenase.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
4-Abz-Gly-Pro-D-Leu-D-Ala-NHOH trifluoroacetate salt
CAS:124168-73-6 |
C23H34N6O6 |
Impaired Focal Adhesion Kinase-Grb2 Interaction during Eleva...
2015-01-01 [Int. J. Mol. Sci. 16 , 15659-69, (2015)] |
Inhibition of matrix metalloproteinases by peptidyl hydroxam...
1994-03-30 [Biochem. Biophys. Res. Commun. 199 , 1442-6, (1994)] |
Vertebrate collagenase inhibitor. II. Tetrapeptidyl hydroxam...
1991-06-01 [Chem. Pharm. Bull. Tokyo 39 , 1489-1494, (1991)] |
Modeling of inhibitor-metalloenzyme interactions and selecti...
1998-04-01 [Proteins 31 , 42-60, (1998)] |
Inhibition of corneal ulceration by tetrapeptidyl hydroxamic...
1995-01-01 [Jpn. J. Ophthalmol. 39 , 35-42, (1995)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved